Reduction of heart rate by omega-3 fatty acids and the potential underlying mechanisms

Jing X Kang1

  • 1Laboratory for Lipid Medicine and Technology, Massachusetts General Hospital and Harvard Medical School Boston, MA, USA.

Frontiers in Physiology
|November 2, 2012
PubMed

Insights

Omega-3 fatty acids reduce heart rate by decreasing cardiac myocyte electrical excitability. This mechanism may explain how omega-3s help prevent sudden cardiac death (SCD).

Area of Science:

  • Cardiovascular Science
  • Molecular Cardiology
  • Pharmacology

Background:

  • Elevated resting heart rate predicts cardiovascular mortality and sudden cardiac death (SCD).
  • Identifying agents to safely reduce heart rate is crucial for SCD prevention.
  • Omega-3 fatty acids have shown potential in reducing heart rate in human and animal studies.

Purpose of the Study:

  • To investigate the cellular mechanisms by which omega-3 fatty acids reduce heart rate.
  • To explore the role of cardiac myocyte electrical excitability in omega-3 induced heart rate reduction.

Main Methods:

  • Investigated the effects of omega-3 fatty acids on cardiac myocyte membrane potential.
  • Assessed the impact of omega-3s on the cardiac myocyte refractory period.
  • Examined the influence of omega-3s on cardiac ion channel activity.

Main Results:

  • Omega-3 fatty acids significantly reduced the resting membrane potential of cardiac myocytes.
  • Omega-3s shortened the refractory period of cardiac myocytes.
  • These effects were attributed to the inhibition of specific ion channels.

Conclusions:

  • Omega-3 fatty acids decrease cardiac myocyte electrical excitability by altering ion channel function.
  • This reduction in excitability is a proposed mechanism for the observed heart rate lowering effect of omega-3s.
  • Omega-3s' heart rate-lowering capability may contribute to their protective role against sudden cardiac death.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...